Allelic frequencies of six polymorphic markers for risk of prostate cancer

Allelic frequencies of six polymorphic markers for risk of prostate cancer

The aim of the present study was to evaluate the distribution of polymorphisms for the androgen receptor (AR) (CAG, StuI, GGN), SRD5A2 (Ala49Thr, Val89Leu) and CYP17 (MspA1) genes that are considered to be relevant for risk of prostate cancer. We studied 200 individuals from two cities in the State...

Full description

Bibliographic Details
Main Authors:	M.L. Ribeiro, A. Santos, A.B. Carvalho-Salles, C. Hackel
Format:	Article
Language:	English
Published:	Associação Brasileira de Divulgação Científica 2002-02-01
Series:	Brazilian Journal of Medical and Biological Research
Subjects:	Prostate cancer Polymorphisms AR SRD5A2 CYP17
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2002000200009

Similar Items

Association of CYP17 and SRD5A2 gene polymorphisms with Prostate cancer risk among Iranian and Indian populations
by: kh onsory, et al.
Published: (2016-02-01)

Hereditary prostate cancer
by: Marta Heise, et al.
Published: (2014-05-01)

Genetic variation and prostate cancer : population-based association studies in Sweden
by: Lindström, Sara
Published: (2007)

Role of CYP17 rs743572 Polymorphism in Benign Prostatic Hyperplasia: A Multivariate Integrated Analysis
by: Hong Weng, et al.
Published: (2019-06-01)

Association Between CYP17 rs743572 Polymorphism and Prostate Cancer Risk: Systematic Review With Meta-Analysis and Trial Sequential Analysis
by: Wei-zhang XU, et al.
Published: (2018-04-01)

Polymorphisms of HPC2/ELAC2 and SRD5A2 (5α-Reductase Type II) Genes in Prostate Cancer
by: İzmirli M, et al.
Published: (2011-01-01)

Association between SRD5A2 rs523349 and rs9282858 Polymorphisms and Risk of Benign Prostatic Hyperplasia: A Meta-Analysis
by: Xian-Tao Zeng, et al.
Published: (2017-09-01)

Molecular Analysis of the SRD5A1 and SRD5A2 Genes in Patients with Benign Prostatic Hyperplasia with Regard to Metabolic Parameters and Selected Hormone Levels
by: Aleksandra Rył, et al.
Published: (2017-10-01)

Association of cytochrome P-45017 (T-34C) polymorphism and the risk of acne vulgaris: a meta-analysis
by: Mazaher Ramezani, et al.
Published: (2020-02-01)

CYP17 polymorphisms are associated with decreased risk of breast cancer in Chinese Han women: a case–control study
by: Yang P, et al.
Published: (2018-07-01)

Differential but Concerted Expression of HSD17B2, HSD17B3, SHBG and SRD5A1 Testosterone Tetrad Modulate Therapy Response and Susceptibility to Disease Relapse in Patients with Prostate Cancer
by: Oluwaseun Adebayo Bamodu, et al.
Published: (2021-07-01)

Association between cytochrome CYP17A1, CYP3A4, and CYP3A43 polymorphisms and prostate cancer risk and aggressiveness in a Korean study population
by: Jun Hyun Han, et al.
Published: (2015-04-01)

Allelic and genotype frequencies of major CYP2B6 polymorphisms in the Pakistani population
by: Sagheer Ahmed, et al.
Published: (2021-03-01)

Role of Single Nucleotide Polymorphism of СУР17А Gene in the Development of Stroke
by: S. Yu. Nikulina, et al.
Published: (2018-09-01)

Frequency of Polymorphism in Aromatase Enzyme Coding Gene with Prostate Cancer Risk in North Indian Population
by: KH Onsory, et al.
Published: (2015-10-01)

Estudo dos genes SRD5A2 e 17BHSD3 em casos de ambiguidade genital em pacientes com cariótipo 46,XY
by: Calais, Flávia Leme, 1983-
Published: (2010)

SINGLE NUCLEOTIDE POLYMORPHISMS (CYP11 ALPHA AND CYP17) AND SERUM SEX HORMONE BINDING GLOBULIN LEVELS IN NORMAL AND POLYCYSTIC OVARY SYNDROME
by: Nauman Aziz, et al.
Published: (2021-08-01)

Characterization With Gene Mutations in Han Chinese Patients With Hypospadias and Function Analysis of a Novel AR Genevariant
by: Lifen Chen, et al.
Published: (2021-06-01)

Common Genetic Variation in CYP17A1 and Response to Abiraterone Acetate in Patients with Metastatic Castration-Resistant Prostate Cancer
by: Moritz Binder, et al.
Published: (2016-07-01)

THE ROLE OF CYP17A1 IN ADENOCARCINOMA OF THE PROSTATE AT SARDJITO GENERAL HOSPITAL
by: Dwi Prayogo, et al.
Published: (2020-01-01)

Association Between CYP17A1, CYB5A Polymorphisms and Efficacy of Abiraterone Acetate/Prednisone Treatment in Castration-Resistant Prostate Cancer Patients
by: Wu X, et al.
Published: (2020-06-01)

Genotype and allelic frequencies of CYP2E1*5B polymorphism in the southwest population of Iran
by: Fatemeh Zanganeh, et al.
Published: (2014-10-01)

Early upregulation of AR and steroidogenesis enzyme expression after 3 months of androgen-deprivation therapy
by: Agus Rizal A. H. Hamid, et al.
Published: (2020-06-01)

Discovery of Novel Non-Steroidal Cytochrome P450 17A1 Inhibitors as Potential Prostate Cancer Agents
by: Tomasz M. Wróbel, et al.
Published: (2020-07-01)

Genistein Combined Polysaccharide (GCP) Can Inhibit Intracrine Androgen Synthesis in Prostate Cancer Cells
by: Neelu Batra, et al.
Published: (2020-08-01)

The Correlation between CYP450 Ile462Val Polymorphism and Prostate Cancer in a Group of Iranian Men
by: Maryam Seydali Route, et al.
Published: (2016-04-01)

Comparisons of Prostate Cancer Inhibitors Abiraterone and TOK-001 Binding with CYP17A1 through Molecular Dynamics
by: Fei Xiao, et al.
Published: (2015-01-01)

Morusflavone, a New Therapeutic Candidate for Prostate Cancer by CYP17A1 Inhibition: Exhibited by Molecular Docking and Dynamics Simulation
by: Sayed Aliul Hasan Abdi, et al.
Published: (2021-09-01)

Evaluation of CYP17A1 and CYP1B1 polymorphisms in male breast cancer risk
by: Piera Rizzolo, et al.
Published: (2019-08-01)

Genetic Polymorphism Cytochrome P450 2A6 Allele *4 and *9: Studi on Glycohemoglobine Level Among Javanese Indonesian Smokers
by: Christine Patramurti, et al.
Published: (2019-08-01)

Molecular Diagnosis of 5α-Reductase Type II Deficiency in Brazilian Siblings with 46,XY Disorder of Sex Development
by: Maricilda Palandi de Mello, et al.
Published: (2011-12-01)

Effect of intercity electric multiple unit projects on regional economic development: evidence from a natural experiment in Zhongshan city, China
by: Heyuan Huang, et al.
Published: (2019-06-01)

mRNA expression of CYP17A1, CYP11A1, CYP19A1, HSD3B1 and AKR1C2 in metastatic and non-metastatic prostate cancer patients
by: Indrawarman Soerohardjo, et al.
Published: (2019-04-01)

The allele frequency of CYP2C9 and VKORC1 in the Southern Khorasan population
by: Fariba Emadian Razavi, et al.
Published: (2017-01-01)

The CYP17A1 rs743572 Gene Polymorphism and Risk of Development and Clinical Features of Acne Vulgaris in the Uzbek Population
by: Nilufar N. Malikova, et al.
Published: (2019-06-01)

Frequencies of 23 functionally significant variant alleles related with metabolism of antineoplastic drugs in the Chilean population: comparison with Caucasian and Asian populations
by: Angela Margarita Roco, et al.
Published: (2012-11-01)

(TTTA)n polymorphism of CYP19 (aromatase gene) in Euro- and Afro-Brazilians
by: Kátia Kvitko, et al.
Published: (2004-01-01)

An Accurate and Compact High Power Monocycle Pulse Transmitter for Microwave Ultra-Wideband Radar Sensors with an enhanced SRD model: Applications for Distance Measurement for lossy materials
by: Y. Ahajjam, et al.
Published: (2019-09-01)

A cross-sectional study to assess any possible linkage of C/T polymorphism in CYP17A1 gene with insulin resistance in non-obese women with polycystic ovarian syndrome
by: Ushasi Banerjee, et al.
Published: (2016-01-01)

MAIN MOLECULAR TARGETS FOR PROSTATE CANCER THERAPY
by: G. S. Krasnov, et al.
Published: (2016-02-01)